Site: |
Dana Farber Cancer Institute |
|||
Address: |
450 Brookline Ave |
|||
City: |
Boston |
|||
State: |
MA |
|||
Zip: |
02215-5450 |
|||
Country: |
USA |
1 |
Completed |
Closed |
Imatinib + BKM120 |
NCT01468688 |
|
1 |
Recruiting |
Active |
IDRX-42 |
NCT05489237 |
|
1 |
Ongoing, but not recruiting |
Closed |
Sunitinib + Regorafenib |
NCT02164240 |
|
1 |
Ongoing, but not recruiting |
Closed |
Cobimetinib + MPDL3280A |
NCT01988896 |
|
2 |
Completed |
Closed |
XL820 |
NCT00570635 |
|
2 |
Completed |
Closed |
Ponatinib (Iclusig) |
NCT01874665 |
|
3 |
Recruiting |
Active |
Ripretinib |
NCT05734105 |
|
1 |
Completed |
Closed |
BGT226 |
NCT00600275 |
|
1 |
Active, not recruiting |
Closed |
QINLOCK
Ripretinib
DCC-2618 |
NCT02571036 |
|
1 |
Completed |
Closed |
GDC-0980 |
NCT00854152 |
|
1 |
Ongoing, but not recruiting |
Closed |
GDC-0980 |
NCT00854126 |
|
2 |
Completed |
Closed |
STA-9090 |
NCT01039519 |
|
1 |
Completed |
Closed |
GDC-0941 + GDC-0973 |
NCT00996892 |
|
3 |
Active, not recruiting |
Active |
QINLOCK
Ripretinib
DCC-2618
SUTENT
Sunitinib |
NCT03673501 |
|
1 |
Ongoing, but not recruiting |
Closed |
GDC-0941 |
NCT00876109 |
|
2 |
Terminated |
Closed |
Olaratumab (IMC-3G3) |
NCT01316263 |
|
1 |
Recruiting |
Active |
NB003 |
NCT04936178 |
|
2 |
Does not allow GIST |
Closed |
R1507 |
NCT00642941 |
|
2 |
Completed |
Closed |
Sunitinib |
NCT01396148 |
|
2 |
Completed |
Closed |
Imatinib |
NCT00237185 |